G
Last Price
52 Week Range
$0.00 - $0.00
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | $3.57K |
EV | - |
Shares Outstanding | 17.88M |
Beta | -56.61 |
Industry | Drug Manufacturers - Specialty & Generic |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Genex Pharmaceutical, Inc.
GENX
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Song, Fuzhi
Employees
86
Website
Data UnavailableIPO Date
2004-03-29
Headquarters
1801 Guangyin Building, Youyibeilu Hexi District, Tianjin 300074, China
Review of Recent GENX Stock Performance trends:Past 1 Month: Genex Pharmaceutical (GENX) shares changed by +100.00%.Past 3 Months: The stock recorded a change of +100.00%.Past 6 Months: GENX shares posted a change of +100.00%. Last updated: March 7, 2026 at 10:52 PM Eastern Time
Over the last year, Genex Pharmaceutical (GENX) has established a 52-week price range between a high of $0.00 and a low of $0.00. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 10:52 PM Eastern Time
Genex Pharmaceutical (GENX) is considered a low volatility stock. It has a beta of -56.61, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 56.61 times the market's movement. Over the past 52 weeks, GENX has traded within a $0.00 – $0.00 range. Last updated: March 7, 2026 at 10:52 PM Eastern Time
The current Genex Pharmaceutical (GENX) market capitalization is approximately $3.57K, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Genex Pharmaceutical's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 10:52 PM Eastern Time
Genex Pharmaceutical (GENX) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, Genex Pharmaceutical (GENX) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice.
Like other publicly traded stocks, Genex Pharmaceutical (GENX) shares are bought and sold on stock exchanges such as OTCPK and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Genex Pharmaceutical (GENX) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add GENX to your watchlist.
Genex Pharmaceutical trades under the ticker symbol GENX on the OTCPK stock exchange. The ticker GENX is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Genex Pharmaceutical (GENX) employs approximately 86 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: March 7, 2026 at 10:52 PM Eastern Time
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers